AlzeCure Pharma AB has a total of 30 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in Brazil, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are COVEX SA, PLIANT THERAPEUTICS INC and WANBURY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 4 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Republic of Korea | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Australia | 2 | |
#7 | Israel | 2 | |
#8 | United States | 2 | |
#9 | Chile | 1 | |
#10 | China | 1 | |
#11 | United Kingdom | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Nordvall Gunnar | 23 |
#2 | Forsell Pontus | 23 |
#3 | Sandin Johan | 5 |
#4 | Gunnar Nordvall | 4 |
#5 | Pontus Forsell | 4 |
#6 | Johan Sandin | 1 |
Publication | Filing date | Title |
---|---|---|
GB201912404D0 | New compounds | |
BR112020026619A2 | COMPOUND, METHOD FOR TREATING AND / OR PREVENTING A DISEASE THAT PRESENTS HARMFUL SIGNALING OF NEUROTROPHINS AND / OR OTHER TROPIC FACTORS, USE OF A COMPOUND, COMBINATION PRODUCT, PARTS KIT, AND, PROCESS FOR THE PREPARATION OF A COMPOUND | |
KR20210028649A | 4-substituted phenyl-1,3,5-triazine derivatives as modulators of the TRK receptor | |
SG11202007136VA | Triazine derivatives for treating diseases relating to neurotrophins | |
US2020113910A1 | Triazinetrione derivatives and their use as modulators of neurotrophin receptor and receptor tyrosine kinases |